Therapeutic targeting of the tumor microenvironment

L Bejarano, MJC Jordāo, JA Joyce - Cancer discovery, 2021 - AACR
Strategies to therapeutically target the tumor microenvironment (TME) have emerged as a
promising approach for cancer treatment in recent years due to the critical roles of the TME …

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

X Xu, M Zhang, F Xu, S Jiang - Molecular cancer, 2020 - Springer
Wnt signaling is a highly conserved signaling pathway that plays a critical role in controlling
embryonic and organ development, as well as cancer progression. Genome-wide …

Targeting macrophages in hematological malignancies: recent advances and future directions

W Li, F Wang, R Guo, Z Bian, Y Song - Journal of hematology & oncology, 2022 - Springer
Emerging evidence indicates that the detection and clearance of cancer cells via
phagocytosis induced by innate immune checkpoints play significant roles in tumor …

CD47 blockade triggers T cell–mediated destruction of immunogenic tumors

X Liu, Y Pu, K Cron, L Deng, J Kline, WA Frazier… - Nature medicine, 2015 - nature.com
Macrophage phagocytosis of tumor cells mediated by CD47-specific blocking antibodies
has been proposed to be the major effector mechanism in xenograft models. Here, using …

Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential

J Liu, L Wang, F Zhao, S Tseng, C Narayanan, L Shura… - PloS one, 2015 - journals.plos.org
CD47 is a widely expressed cell surface protein that functions as a regulator of phagocytosis
mediated by cells of the innate immune system, such as macrophages and dendritic cells …

[HTML][HTML] Cancer immunotherapy targeting the CD47/SIRPα axis

K Weiskopf - European journal of cancer, 2017 - Elsevier
The success of cancer immunotherapy has generated tremendous interest in identifying new
immunotherapeutic targets. To date, the majority of therapies have focussed on stimulating …

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

SB Willingham, JP Volkmer… - Proceedings of the …, 2012 - National Acad Sciences
CD47, a “don't eat me” signal for phagocytic cells, is expressed on the surface of all human
solid tumor cells. Analysis of patient tumor and matched adjacent normal (nontumor) tissue …

[HTML][HTML] Dendritic cells but not macrophages sense tumor mitochondrial DNA for cross-priming through signal regulatory protein α signaling

MM Xu, Y Pu, D Han, Y Shi, X Cao, H Liang, X Chen… - Immunity, 2017 - cell.com
Inhibition of cytosolic DNA sensing represents a strategy that tumor cells use for immune
evasion, but the underlying mechanisms are unclear. Here we have shown that CD47-signal …

[HTML][HTML] CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells

R Majeti, MP Chao, AA Alizadeh, WW Pang, S Jaiswal… - Cell, 2009 - cell.com
Acute myeloid leukemia (AML) is organized as a cellular hierarchy initiated and maintained
by a subset of self-renewing leukemia stem cells (LSC). We hypothesized that increased …

The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications

MP Chao, IL Weissman, R Majeti - Current opinion in immunology, 2012 - Elsevier
Multiple lines of investigation have demonstrated that the immune system plays an important
role in preventing tumor initiation and controlling tumor growth. Accordingly, many cancers …